Late (> 48 hr) myocardial infarction after PTCA: Clinical and angiographic characteristics of infarction related or not to the angioplasty site

Catheterization and Cardiovascular Interventions

Volumn 53, Issue 2, 2001, Pages 155-162

  Rodes, Josep ^a   Tanguay, Jean Francois ^a   Bertrand, Olivier F ^a,b   Malekianpour, Mehrdad ^a   Lesperance, Jacques ^a   Ce, Gilles ^a   Theroux, Pierre ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Coronary; Infarction; Ischemia; PTCA; Vein graft

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; RISK FACTOR; SAPHENOUS VEIN GRAFT; SCORING SYSTEM; SEX DIFFERENCE; STATISTICAL ANALYSIS; VEIN GRAFT;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TIME FACTORS;

EID: 0034995890     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.1142     Document Type: Article

References (21)

1. Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty
2. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty
3. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
4. Creatine kinase release after catheter-based coronary intervention
5. Cause of acute myocardial infarction after successful coronary angioplasty
6. Causes of coronary events after successful coronary angioplasty
7. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction
8. Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: An analysis from the Thrombolysis In Myocardial Ischemia (TIMI) III trials
9. Protocol for the bypass angioplasty revascularization investigation
10. Guidelines for percutaneous transluminal coronary angioplasty: A report of the American College of Cardiology/ 0American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty)
11. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: Implications for patient selection
12. Lesion morphology and coronary angioplasty: Current experience and analysis
13. Coronary angiographic morphology in myocardial infarction: A link between the pathogenesis of unstable angina and myocardial infarction
14. Correlation of angiographic morphology and clinical presentation in unstable angina
15. The Thrombolysis In Myocardial Infarction (TIMI) trial: Phase I findings
16. Late angiographic status of coronary angioplasty site which was < 50% narrowed 4 to 12 months after successful angioplasty
17. Restenosis after successful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 229 patients
18. Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon
19. Therapeutic dissection after successful coronary balloon angioplasty: No influence on restenosis or on clinical outcome in 693 patients
20. The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting
21. Percutaneous transluminal angioplasty of saphenous vein graft stenosis: Long-term follow-up